Effect of union treatment of lovastatin and irbesartan on osteopontin expression and tubulointerstitial fibrosis in obstructive nephropathy rats

YANG Xia,SUN Zhaolin,YUAN Jing,ZHA Yan,HE Pinghong,HU Ying

DOI: https://doi.org/10.3969/j.issn.1674-4721.2013.18.004

2013-01-01

Abstract:Objective To investigate the effects of union treatment of lovastatin and irbesartan on the expression of osteopontin (OPN) and renal tubulointerstitial fibrosis. Methods Experimental SD rats were randomly divided into four groups (n = 10) respectively:sham operation group,unilateral ureteral ligation operation group (UUO group),irbesartan group (60 mg/L) and combination group (with 20 mg/L lovastatin combined 60 mg/L irbesartan).The rats in sham operation group and UUO group were treated with equal normal saline.After 6 weeks,observing renal function,histopathological changes and 24-hours proteinuria,and detecting the expression of OPN in renal interstitium. Results Irbesartan treatment could reduce the expression of OPN compared with model group ( P < 0.05),24 h urinary albumin and serum creatinine (Scr) decreased (P < 0.05) and alleviate the damages of renal histopathology,renal tubular interstitial area was significantly reduced in the model group (P < 0.01);And lovastatin combined irbesartan treatment,the expression of OPN reduced more significantly,renal function and kidney pathology damage improvement was more obvious. Conclusion By the combined treatment of lovastatin and irbesartan,the expression of OPN is significantly decreased and renal interstitial fibrosis is obviously ameliorated in obstructive nephropathy rats.